Market Report, "ARK Diagnostics, Inc. - Product Pipeline Analysis, 2014 Update", Published
ARK Diagnostics, Inc. (ARK Diagnostics) is a medical device company. The company designs, manufactures, and distributes in vitro diagnostic immunoassays for managing drug levels. Its products include protease inhibitors, ARK levetiracetam assay, ARK topiramate assay, non-nucleoside reverse transcriptase inhibitors, ARK gabapentin assay, ARK lamotrigine assay, ARK zonisamide assay, ARK methotrexate assay, ARK thyroxine assay, and entry inhibitor. ARK Diagnostics offers products for epilepsy and pain management, cancer, veterinary, and HIV or AIDS. The company offers protease inhibitors such as ritonavir,...
View full press release